Abstract:1. The total body calcium (Expt 1) of litter-mate male rats given a diet adequate in phosphorus and high (0·74%) or low (0·13%) in Ca from the age of 3 weeks was determined after 21, 48 and 60 weeks on the diet. In Expt 2, the ash content of ten groups of bones from 10-week-old rats given these same diets for 7 weeks was studied to ascertain whether all groups were equally affected by the difference in dietary Ca level. Four groups of bones, i.e. skull and mandibles, vertebras, the shafts and the ends of long bones, were consequently chosen for examination in Expt 3 where their growth and composition were studied in rats given the Ca diets for 24, 48 or 60 weeks from the age of 3 weeks. 2. Total body Ca (Expt 1), expressed as g Ca or as a percentage of the net body-weight or of net dry, fat-free carcass weight, was always significantly higher in rats given the higher level of Ca. The dietary effect was greatest after 21 weeks. 3. The higher level of dietary Ca led to a highly significant increase in the weight of the dry, fat-free bone and in the percentage ash content of all ten bone groups after 7 weeks (Expt 2). The greater treatment differences in ash content occurred with the less well mineralized bones. 4. In Expt 3, irrespective of diet, the four groups of bones developed at different rates. In rats given the diets for 24 weeks or longer, the vertebras and the shafts of long bones showed the greatest proportional increase in weight of dry, fat-free bone and ash relative to the corresponding values for 3-week-old rats; the greatest change in percentage ash content occurred in the ends of the long bones. 5. Increasing the level of Ca in the diet increased the weight of the dry, fat-free bone and its ash content. The effect of diet decreased with increasing time on the diets, in general persisting most strongly in the skull and mandibles and declining most rapidly in the ends of the long bones. The percentage Ca and P content of the bone ash was only slightly affected by diet and, except for the Ca in the ash of vertebras, significant differences were only found in the composition of the ash of bones from 27-week-old rats.

A single-phase PWM inverter controlling based on PLL compensation with nonlinear loads

Prokaryotic Expression of Structural Protein VP1 of Foot-and-mouth disease virus Type O and Analysis of Its Antigenicity

Development of Tobacco necrosis virus A as a vector for efficient and stable expression of FMDV VP1 peptides.

Prokaryotic Expression and Activity Analysis of VP1 Gene of Foot-and-Mouth Disease Virus Serotype O

Prokaryotic Expression and Activity Analysis of VP1 of Foot-and-Mouth Disease Virus Serotype A

A Novel Mucosal Vaccine Against Foot-and-Mouth Disease Virus Induces Protection in Mice and Swine

Development of recombinant vp1 protein immunised in mice as a model of foot-and-mouth disease vaccine

Antigenicity and Immunogenicity Analysis of the E. coli Expressed FMDV Structural Proteins; VP1, VP0, VP3 of the South African Territories Type 2 Virus

Potent immune responses against thermostable Foot-and-Mouth disease virus VP1 nanovaccine adjuvanted with polymeric thermostable scaffold

Expression and Immunogenicity of Two Recombinant Fusion Proteins Comprising Foot-and-Mouth Disease Virus Structural Protein VP1 and DC-SIGN-Binding Glycoproteins

Detection of Foot-and-mouth Virus Antibodies Using a Purified Protein from the High-Level Expression of Codon-Optimized, Foot-and-mouth Disease Virus Complex Epitopes in Escherichia Coli.

Development of an Indirect ELISA Based on VP1-CRT Fusion Protein for Detection of FMDV-O in Swine

B cell epitopes within VP1 of type O foot-and-mouth disease virus for detection of viral antibodies

High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha.

Immunogenicity and protective efficacy of recombinant proteins consisting of multiple epitopes of foot-and-mouth disease virus fused with flagellin

Soluble Expression and Immuneoreactivity Analysis of FMDV VP0 and VP1 Protein

Effect of level of dietary calcium on the skeleton of the rat

Expression of the VP1 protein of FMDV integrated chromosomally with mutant Listeria monocytogenes strain induced both humoral and cellular immune responses

Soluble FMDV VP1 Proteins Fused with Calreticulin Expressed in Escherichia Coli under the Assist of Trigger Factor16 (tf16) Formed into High Immunogenic Polymers.

Immunogenicity of Recombinant Fowl-Pox Virus Co-Expressing Structural Protein Precursor P1-2A and Proteinase 3C of FMDV

A novel immunoinformatics approach for developing a poly-epitope vaccine targeting foot and mouth disease virus, exploiting structural VP proteins